Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03779295

Laser Therapy for Perioral Dermatitis

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
West Virginia University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Perioral dermatitis is an inflammation of the skin around the mouth. The cause of perioral dermatitis is unknown. Current treatment methods include oral antibiotics and topical calcenurin inhibitors, both of which produce side effects and have been relatively ineffective in the treatment of perioral dermatitis. The investigators hope to assess the efficacy of laser therapy in treatment of perioral dermatitis by using laser therapy on one half of the patients face and having patients apply topical medication (clindamycin) to their face for 8 weeks. The side of their face that receives laser therapy will be randomized. The investigators will assess the efficacy of laser therapy by counting the number of lesions that patients have before and after laser therapy, comparing photos of patient's perioral dermatitis before and after treatment, and having patient's rate their satisfaction of the treatment.

Conditions

Interventions

TypeNameDescription
DEVICEPulse laser dye therapy (Device name: Candela Family of Pulsed Dye Laser Systems. 501k Number: K050673.)The face will be split and randomized, one half will receive pulsed laser dye therapy.
DRUGClindamycinThe entire face (both halves) will receive clindamycin.

Timeline

Start date
2018-11-01
Primary completion
2019-06-05
Completion
2019-06-05
First posted
2018-12-19
Last updated
2022-03-03

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03779295. Inclusion in this directory is not an endorsement.

Laser Therapy for Perioral Dermatitis (NCT03779295) · Clinical Trials Directory